Boulder, CO
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Apeiron Research Center, founded in 2024, is a community nonprofit in the Medical Research sector that reported $4.8M in total revenue in fiscal year 2025. The organization ran a surplus of $3.3M, a strong 69% operating margin.
Apeiron Research Center conducts translational biomedical research focused on autologous cellular and biologic therapies, including bone marrowderived, adipose-derived, and platelet-based products. Program activities include laboratory characterization of biologic materials, development and validation of standardized processing methods, preclinical safety studies, and ethically supervised clinical research evaluating safety and biologic function. A central program objective is the structured advancement of research findings toward regulatory-compliant autologous Good Manufacturing Practice (GMP) processes that may support future clinical trials and evidence-based therapeutic applications. The organization maintains comprehensive quality management systems to ensure reproducibility, patient protection, and alignment with applicable federal and state regulatory standards. Research results contribute to scientific knowledge.
Apeiron Research Center conducts translational biomedical research focused on autologous cellular and biologic therapies, including bone marrowderived, adipose-derived, and platelet-based products...
Apeiron Research Center conducts translational biomedical research focused on autologous cellular and biologic therapies, including bone marrowderived, adipose-derived, and platelet-based products. Program activities include laboratory characterization of biologic materials, development and validation of standardized processing methods, preclinical safety studies, and ethically supervised clinical research evaluating safety and biologic function. A central program objective is the structured advancement of research findings toward regulatory-compliant autologous Good Manufacturing Practice (GMP) processes that may support future clinical trials and evidence-based therapeutic applications. The organization maintains comprehensive quality management systems to ensure reproducibility, patient protection, and alignment with applicable federal and state regulatory standards. Research results contribute to scientific knowledge
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $4,811,542 | N/A | N/A |
| Expenses | $1,506,305 | N/A | N/A |
| Net Income | $3,305,237 | $0 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Jason Glowney | President/Principal Investigator | 50.00 |
Officer
|
$350,385 | $2,531 | $352,916 |
| Robert Pickels | Director of Operations | 50.00 |
Officer
|
$145,385 | $2,369 | $147,754 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $4,811,542 | $1,506,305 | $4,554,544 | $3,305,237 |
Compare Apeiron Research Center with other nonprofits in Colorado and across the country.